Rigrodsky & Long, P.A. Investigates Penwest Pharmaceuticals Co. Buyout
10 Agosto 2010 - 12:22PM
Business Wire
Rigrodsky & Long, P.A. announces that it is investigating
potential claims against the board of directors of Penwest
Pharmaceuticals Co. (“Penwest” or the “Company”) (Nasdaq: PPCO)
concerning possible breaches of fiduciary duty and other violations
of law related to the Company’s entry into an agreement to be
acquired by Endo Pharmaceuticals Holdings, Inc. (“Endo”) (Nasdaq:
ENDP) in a transaction with an enterprise value of approximately
$144 million.
(http://www.rigrodskylong.com/news/PenwestPharmaceuticals-PPCO).
Under the proposed agreement, Endo will shortly commence an
all-cash tender offer to acquire 100 percent of the outstanding
common stock of Penwest for $5.00 per Penwest share. The tender
offer is expected to be completed in September, 2010. Endo will
acquire any Penwest shares that are not purchased in the tender
offer in a second-step merger which is expected to be completed
during the fourth quarter of 2010 at the same price per share paid
in the tender offer.
The investigation concerns whether Penwest’s board of directors
failed to adequately shop the Company and obtain the best price
possible for Penwest’s shareholders before entering into the
agreement with Endo. Additionally, Tang Capital Partners, LP, and
Perceptive Advisors LLC, shareholders of Penwest, and Jennifer
Good, Penwest’s President and CEO, who collectively own 38.6% of
fully diluted common stock of Penwest, have committed to tender
their shares in the tender offer.
If you own the common stock of Penwest and purchased your shares
before August 9, 2010, if you have information or would like to
learn more about these claims, or if you wish to discuss these
matters or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development
Director, of Rigrodsky & Long, P.A., 919 N. Market Street,
Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or
by e-mail to info@rigrodskylong.com.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly litigates securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, including claims for breach of
fiduciary duty and proxy violations in the Delaware Court of
Chancery and in state and federal courts throughout the United
States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Penwest (NASDAQ:PPCO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Penwest (NASDAQ:PPCO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024